---
figid: PMC8564637__MOL2-15-3147-g005
figtitle: MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter
  methylation and expression through the HB‐EGF/EGFR pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8564637
filename: MOL2-15-3147-g005.jpg
figlink: /pmc/articles/PMC8564637/figure/mol213019-fig-0007/
number: F7
caption: Proposed model of MeCP2 binding to the HOXD3 upstream methylated promoter
  via the HB‐EGF–EGFR‐ERK1/2 signaling pathway to regulate the invasion, metastasis,
  and angiogenesis of HCC.
papertitle: MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3
  promoter methylation and expression through the HB‐EGF/EGFR pathway.
reftext: Lumin Wang, et al. Mol Oncol. 2021 Nov;15(11):3147-3163.
year: '2021'
doi: 10.1002/1878-0261.13019
journal_title: Molecular Oncology
journal_nlm_ta: Mol Oncol
publisher_name: John Wiley and Sons Inc.
keywords: HB‐EGF | HCC | HOXD3 | MeCP2 | methylation | progression
automl_pathway: 0.9352829
figid_alias: PMC8564637__F7
figtype: Figure
redirect_from: /figures/PMC8564637__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8564637__MOL2-15-3147-g005.html
  '@type': Dataset
  description: Proposed model of MeCP2 binding to the HOXD3 upstream methylated promoter
    via the HB‐EGF–EGFR‐ERK1/2 signaling pathway to regulate the invasion, metastasis,
    and angiogenesis of HCC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MECP2
  - CREB1
  - HOXD3
  - HBEGF
  - EPHB2
  - MAPK1
  - MAPK3
  - KRAS
  - HRAS
  - NRAS
  - EGFR
---
